Breast oncology Clinical Trials in San Antonio, TX

As of September 2026, 53 paid clinical trials are recruiting for Breast oncology in San Antonio, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

53 clinical trials for Breast oncology

·Clear filters·

Email me when a new breast oncology trial opens in San Antonio, TX.

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

for Breast Cancer

Sites in San Antonio, Cypress +1098 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 18 - 60

Code: NCT05879926·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

for Acute Lymphoblastic Leukemia

Sites in San Antonio, Amarillo +616 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 40 - 75·Accepts healthy volunteers

Code: NCT05334069·Recruiting·Listed Apr 2022

Apply to this trial

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

for Anatomic Stage IV Breast Cancer AJCC v8

Sites in San Antonio, Sugar Land +255 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06500455·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

for HER2-negative Breast Cancer

Sites in San Antonio, Dallas +3 more locations

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18 - 99

Code: NCT05029999·Phase 1·Recruiting·Listed Sep 2021

Apply to this trial

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

for Breast Cancer

Sites in San Antonio, Houston +2 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07076485·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for Breast Cancer

Sites in San Antonio, Dallas +5 more locations

Sponsor: SCRI Development Innovations, LLC

Sex: All·Age: 18+

Code: NCT05748834·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

for Melanoma

Sites in San Antonio, Houston +4 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07115043·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

for Hepatocellular Carcinoma

Drug: ABBV-400

1 location in San Antonio

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06084481·Phase 1·Recruiting·Listed Oct 2023

Apply to this trial

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

for Breast Cancer

Sites in San Antonio, Houston +10 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT05307705·Phase 1·Recruiting·Listed Apr 2022

Apply to this trial

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for Advanced Breast Cancer

Drug: Camizestrant

Sites in San Antonio, Houston +36 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06380751·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

for Melanoma (Skin)

Sites in San Antonio, Dallas +3 more locations

Sponsor: Hummingbird Bioscience

Sex: All·Age: 18+

Code: NCT06956690·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

for Triple Negative Breast Cancer

Sites in San Antonio, Austin +8 more locations

Sponsor: Dren Bio

Sex: All·Age: 18+

Code: NCT06999187·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

for Breast Cancer

Sites in San Antonio, Houston +4 more locations

Sponsor: Biotheryx, Inc.

Sex: All·Age: 18+

Code: NCT06515470·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

Conditions in Breast oncology (San Antonio, TX)

Breast cancer· 32 Metastatic breast cancer· 14 Triple-negative breast cancer· 11 HER2-negative breast cancer· 5 HER2-positive breast cancer· 2